Atlantic Trust Group LLC lifted its holdings in Healthequity Inc (NASDAQ:HQY) by 9.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 296,002 shares of the company’s stock after acquiring an additional 25,647 shares during the quarter. Atlantic Trust Group LLC owned approximately 0.49% of Healthequity worth $14,972,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Zions Bancorporation bought a new position in Healthequity in the 3rd quarter worth approximately $119,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Healthequity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after purchasing an additional 1,308 shares during the last quarter. Riverhead Capital Management LLC raised its position in Healthequity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after purchasing an additional 1,129 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in Healthequity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after purchasing an additional 191 shares during the last quarter. Finally, D.A. Davidson & CO. raised its position in Healthequity by 15.2% in the 2nd quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock worth $165,000 after purchasing an additional 439 shares during the last quarter. 98.27% of the stock is currently owned by institutional investors and hedge funds.

Shares of Healthequity Inc (HQY) opened at $48.80 on Monday. The company has a market cap of $2,960.00, a price-to-earnings ratio of 65.95, a price-to-earnings-growth ratio of 2.01 and a beta of 1.74. Healthequity Inc has a 1 year low of $37.62 and a 1 year high of $55.31.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business’s revenue for the quarter was up 31.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.10 EPS. equities analysts expect that Healthequity Inc will post 0.71 earnings per share for the current year.

In related news, Director Frank Medici sold 316,644 shares of the company’s stock in a transaction on Monday, October 9th. The shares were sold at an average price of $51.96, for a total value of $16,452,822.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Berkley Capital, Llc sold 286,512 shares of the company’s stock in a transaction on Thursday, October 5th. The shares were sold at an average price of $51.96, for a total transaction of $14,887,163.52. The disclosure for this sale can be found here. Insiders have sold a total of 1,761,117 shares of company stock valued at $91,915,316 in the last quarter. Corporate insiders own 29.00% of the company’s stock.

Several research analysts recently weighed in on the stock. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a research report on Wednesday, October 11th. Oppenheimer restated a “buy” rating and issued a $61.00 price objective on shares of Healthequity in a research report on Wednesday, September 6th. Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a research report on Tuesday, August 29th. Finally, Robert W. Baird reiterated a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $58.33.

TRADEMARK VIOLATION NOTICE: “Healthequity Inc (HQY) Stake Lifted by Atlantic Trust Group LLC” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://theolympiareport.com/2017/12/25/healthequity-inc-hqy-stake-lifted-by-atlantic-trust-group-llc.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with Analyst Ratings Network's FREE daily email newsletter.